Shu Hsuan Tsai
Chief Executive Officer at NIEN HSING TEXTILE CO., LTD.
Profile
Shu Hsuan Tsai is currently the President, GM Director & Spokesman at Nien Hsing Textile Co., Ltd.
and a Director at Nien Hsing International Investment Corp., Mycenax Biotech, Inc., and Leadray Energy Co., Ltd.
Previously, Mr. Tsai held positions as a Director at TPG Biologics, Inc., Lumosa Therapeutics Co., Ltd., and BioGend Therapeutics Co., Ltd.
Mr. Tsai completed their undergraduate degree at Soochow University.
Shu Hsuan Tsai active positions
Companies | Position | Start |
---|---|---|
MYCENAX BIOTECH INC. | Director/Board Member | 2017-06-14 |
NIEN HSING TEXTILE CO., LTD. | Chief Executive Officer | 2015-03-31 |
Nien Hsing International Investment Corp. | Director/Board Member | - |
Leadray Energy Co., Ltd.
Leadray Energy Co., Ltd. Electrical ProductsProducer Manufacturing Leadray Energy Co., Ltd. is a Taiwanese company that manufactures LED lights. | Director/Board Member | - |
Former positions of Shu Hsuan Tsai
Companies | Position | End |
---|---|---|
BIOGEND THERAPEUTICS CO., LTD. | Director/Board Member | - |
LUMOSA THERAPEUTICS CO., LTD. | Director/Board Member | - |
TPG BIOLOGICS INC | Director/Board Member | - |
Training of Shu Hsuan Tsai
Soochow University /Taiwan/ | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
MYCENAX BIOTECH INC. | Health Technology |
NIEN HSING TEXTILE CO., LTD. | Process Industries |
BIOGEND THERAPEUTICS CO., LTD. | Commercial Services |
LUMOSA THERAPEUTICS CO., LTD. | Health Technology |
Private companies | 3 |
---|---|
Nien Hsing International Investment Corp. | |
Leadray Energy Co., Ltd.
Leadray Energy Co., Ltd. Electrical ProductsProducer Manufacturing Leadray Energy Co., Ltd. is a Taiwanese company that manufactures LED lights. | Producer Manufacturing |
TPG Biologics, Inc.
TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Shu Hsuan Tsai